These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21572545)

  • 1. Neuroprotective fractalkine in fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong C
    Am J Obstet Gynecol; 2011 May; 204(5):400.e1-3. PubMed ID: 21572545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong CY
    Am J Obstet Gynecol; 2012 Dec; 207(6):499.e1-5. PubMed ID: 23174390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the alcohol-induced changes in brain-derived neurotrophic factor expression using neuroprotective peptides in a model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Benassou I; Abebe D; Spong CY
    Am J Obstet Gynecol; 2010 May; 202(5):457.e1-4. PubMed ID: 20452488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
    Poggi SH; Goodwin K; Hill JM; Brenneman DE; Tendi E; Schinelli S; Abebe D; Spong CY
    Am J Obstet Gynecol; 2003 Sep; 189(3):790-3. PubMed ID: 14526315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome.
    Toso L; Roberson R; Abebe D; Spong CY
    Am J Obstet Gynecol; 2007 Mar; 196(3):259.e1-5. PubMed ID: 17346546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with neuropeptides attenuates c-fos expression in a mouse model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Abebe D; Spong CY
    Am J Perinatol; 2010 Oct; 27(9):743-8. PubMed ID: 20446212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disorders.
    Kane CJM; Douglas JC; Rafferty T; Johnson JW; Niedzwiedz-Massey VM; Phelan KD; Majewska AK; Drew PD
    J Neurosci Res; 2021 Aug; 99(8):1986-2007. PubMed ID: 33533128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
    Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF
    Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and gamma-aminobutyric acid receptors.
    Vink J; Incerti M; Toso L; Roberson R; Abebe D; Spong CY
    Am J Obstet Gynecol; 2009 May; 200(5):524.e1-4. PubMed ID: 19327737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 response mediates ethanol-induced neurodevelopment alterations in a model of fetal alcohol spectrum disorders.
    Pascual M; Montesinos J; Montagud-Romero S; Forteza J; Rodríguez-Arias M; Miñarro J; Guerri C
    J Neuroinflammation; 2017 Jul; 14(1):145. PubMed ID: 28738878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse.
    Sari Y; Weedman JM; Nkrumah-Abrokwah M
    J Mol Neurosci; 2013 Jan; 49(1):150-6. PubMed ID: 23229836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal treatment prevents learning deficit in Down syndrome model.
    Incerti M; Horowitz K; Roberson R; Abebe D; Toso L; Caballero M; Spong CY
    PLoS One; 2012; 7(11):e50724. PubMed ID: 23209818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss.
    Zhou FC; Fang Y; Goodlett C
    Alcohol Clin Exp Res; 2008 Aug; 32(8):1361-71. PubMed ID: 18565153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders.
    Drew PD; Johnson JW; Douglas JC; Phelan KD; Kane CJ
    Alcohol Clin Exp Res; 2015 Mar; 39(3):445-54. PubMed ID: 25703036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress.
    Ślusarczyk J; Trojan E; Głombik K; Chamera K; Roman A; Budziszewska B; Basta-Kaim A
    Neural Plast; 2016; 2016():7258201. PubMed ID: 27239349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.
    Roche SL; Wyse-Jackson AC; Gómez-Vicente V; Lax P; Ruiz-Lopez AM; Byrne AM; Cuenca N; Cotter TG
    PLoS One; 2016; 11(11):e0165197. PubMed ID: 27814376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
    Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
    Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of learning deficit in a Down syndrome model.
    Incerti M; Toso L; Vink J; Roberson R; Nold C; Abebe D; Spong CY
    Obstet Gynecol; 2011 Feb; 117(2 Pt 1):354-361. PubMed ID: 21252750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.